Crowd of penguins

Antarctic Wildlife Health Network - Action Group

The risk of new and emerging infectious diseases impacting Antarctica’s wildlife has significantly increased over the last decade, due to climate change, habitat change, human activity and alterations in species distributions. As seen by the recent highly pathogenicity avian influenza (HPAI) H5N1 outbreaks, SCAR’s ability to provide expert advice and guidance to Antarctic stakeholders via the completion of risk assessments, and information papers, and leadership in this field is of high importance. The aim of this Action group will be to bring together experts in the field of Antarctic Wildlife Disease, to better understand, address and provide expert advice to the Antarctic community on the threat infectious diseases pose to Antarctic Wildlife.

 

About

Currently Antarctica is suffering environmental changes due to global change, including climate change and local human activities, that could increase the risk of infectious and non-infectious diseases in wildlife. Current knowledge on bacteria, parasites and viruses and non-infectious diseases in Antarctic wildlife is scarce with limited baseline data or ongoing monitoring programmes.

Two key priorities listed in SCAR’s Horizon Scan, ‘Understanding how climate change will affect the risk of spreading emerging infectious diseases in Antarctica?’ (Q56) and ‘how will humans, diseases and pathogens change, impact and adapt to the extreme Antarctic environment?’ (Q80), are a key focus on the Action Group.

The Antarctic Wildlife Health Network Action Group (formally EG-BAMM’s Antarctic Wildlife Health Network Working Group) aims to improve our understanding and provide expert advice on current, novel and emerging disease and toxicology threats to Antarctic Wildlife.

The Action Group will specifically focus on the following objectives:

  • Provide expert advice and risk assessments on pathogens and disease risk in Antarctic wildlife to the ATCM, and Antarctic Stakeholders (e.g. IAATO, COMNAP, CCAMLR, etc)
  • Conduct risk assessments on current and emerging diseases.
  • Monitor abundance and distribution of pathogens of concern in Antarctic Wildlife
  • Establishment of a central database for pathogens and disease outbreaks (expansion of SCAR HPAI database) and unusual mortality events in Antarctic wildlife.
  • Identify novel and emerging pathogens of concern and assess their risks to Antarctic wildlife.
  • To work with other components and scientific programmes of SCAR (Ant-ICON, ImPACT, JEGHBM, EG‐ABI, AntaBIF) and key Antarctic Research Initiatives (e.g. Securing Antarctica’s Environmental Future) to achieve multidisciplinary approaches to animal health issues.

News and updates from the AWHN-AG research community.

 

 

Members

Contact

The Chief Officer of AWHN-AG is Meagan Dewar. Michelle Wille and Arvind Varsani are part of the group leadership.

Open membership is divided into “Contributing Members” and “Interested Members”. Contributing members are members with expertise in areas of wildlife disease and able to contribute to the activities of the group. Whilst interested members are those that wish to stay up to date with the group’s activities.

Call for applications to the steering committee will be made in 2025. The steering committee will be appointed from the membership.

Resources

Publications, Data and Links of interest to the Antarctic Wildlife Health Network.

Reports
Publications